Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 21 (1), 88-94
- https://doi.org/10.1016/s0168-8278(94)80142-8
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: A double-blind, placebo-controlled studyHepatology, 1992
- Postprandial changes in portal haemodynamics in patients with cirrhosis.Gut, 1992
- The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosisJournal of Hepatology, 1990
- Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver diseaseHepatology, 1989
- Postprandial hemodynamic responses in patients with cirrhosisHepatology, 1988
- The effect of a long‐acting somatostatin analogue (SMS 201–995) on intermediary metabolism and gut hormones after a test meal in normal subjectsAlimentary Pharmacology & Therapeutics, 1987
- The Influence of a Long-Acting Somatostatin Analogue on Splanchnic Haemodynamics and Metabolism in Healthy Subjects and Patients with Liver CirrhosisScandinavian Journal of Gastroenterology, 1986
- Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in manBritish Journal of Surgery, 1985
- Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.JCI Insight, 1977
- Indocyanine Green Clearance and Estimated Hepatic Blood Flow during Mild to Maximal Exercise in Upright Man *JCI Insight, 1964